he Guidant Corporation, already under scrutiny for delaying disclosures about flawed products
June 25, 2005 07:41

The Guidant Corporation, already under scrutiny for delaying disclosures about flawed products, urged doctors to stop implanting its most sophisticated heart devices because of a fault that might cause some of the 40,000 units already implanted not to work properly. The move could have significant financial consequences for Guidant because it affects, for now, sales of many of the company's heart devices in the fastest-growing part of the market: advanced defibrillators that also act as pacemakers for both sides of the heart.
Barry Meier, The New York Times, 06/25/2005 For complete story, search http://query.nytimes.com/search/advanced?srchst=nyt